Should I Buy TAK Stock in 2026?
Data-driven analysis and honest assessment for Takeda Pharmaceutical Co Ltd
Current Price: $17.78P/E: 81.1
Decision Score
Hold
Based on 6 fundamental factors
Score Breakdown:
Very high P/E of 81.1 suggests overvaluation
Slow growth of 2%
Thin margins (0% net)
Financial health data limited
Excellent FCF yield of 1581.4%
No recent insider activity
Key Investment Metrics
Current Price
$17.78
P/E Ratio
81.14
Revenue Growth
0.0%
Profit Margin
0.0%
Market Cap
$56.4B
Dividend Yield
0.04%
How TAK Compares to Competitors
Understanding how TAK stacks up against peers helps inform your investment decision.
How TAK Compares to Peers
Upcoming Events for TAK
+5 Reasons TO Buy TAK
1. High free cash flow yield of 1581.4%
strongFCF yield above 5% means substantial cash generation for dividends, buybacks, or reinvestment.
2. High gross margins of 66%
moderateGross margins above 50% typically indicate strong brand value or intellectual property moats.
-5 Reasons NOT to Buy TAK
1. Expensive valuation at 81x earnings
high riskP/E of 81 is significantly above averages. High expectations leave little room for disappointment.
2. Thin profit margins of 0.0%
high riskLow margins provide little cushion against cost increases or pricing pressure.
3. Minimal revenue growth
low riskGrowth of 0.0% barely keeps pace with inflation.
Who Should Buy TAK?
Investment Profile
Risk Level
High
Recommended Holding Period
3-5 years
Best For:
- ✓
Momentum Traders
High-growth profile attracts momentum
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
- ✗
Value Investors
Premium P/E of 81 doesn't fit value criteria
- ✗
Income-Focused Retirees
Low 0.0% yield
- ✗
Risk-Averse Investors
High risk may cause uncomfortable volatility
Consider These Alternatives
If you're interested in TAK, compare these Health Care peers:
Pro tip: Compare TAK directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for TAK
Frequently Asked Questions
What is TAK stock price today?
TAK (Takeda Pharmaceutical Co Ltd) stock is trading at $17.78 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is TAK stock going up or down today?
TAK stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy TAK stock now?
The decision to buy TAK depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is TAK a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for TAK based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is TAK stock overvalued or undervalued?
TAK currently trades at a P/E ratio of 81.14, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if TAK is fairly priced.
What is TAK's P/E ratio?
TAK has a price-to-earnings (P/E) ratio of 81.14, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is TAK's market cap?
TAK (Takeda Pharmaceutical Co Ltd) has a market capitalization of $56.39 billion, making it a mid-cap stock.
What is TAK's price to book ratio?
TAK trades at a price-to-book (P/B) ratio of 1.17, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Takeda Pharmaceutical Co Ltd
Full Stock Analysis
Complete TAK overview with charts and data
Is TAK Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how TAK stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Takeda Pharmaceutical Co Ltd
Complete TAK Analysis
Compare TAK With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.